TrialTargeted oncology2018
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
Maria Alsina et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it